Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
George,
I think it is the L. I would say the results are amazing too. I don't think poly-iclc was included.
https://aacrjournals.org/clincancerres/article/22/13/3182/79179/Adjuvant-Immunotherapy-to-Improve-Outcome-in-High
ILT,
How could we not know the combo is working? For me, it is definitive it is is working amazingly. There are no theoretical conversations. What we need is just some logical and commonsense reasoning.
Take the colorectal cancer trial as an example. There are no data at all. But what we do see is that the research focus of immunotherapy institute at Mainz has been completely focusing on dendritic cell related stuff. They bought the instruments for protemoic analysis. There is also dramatic increase in publications on dendrtic cell. The CEO of BioNTech at Germany was a professor from Mainz. He still is now probably. BioNtech was supposed to start its trial at UK about its mRNA cancer vaccine in 2026. Boy, BioNtech was in such a big hurry and started last December. Does the company get a lion chasing them?
I don't need to mention about glioblastoma.
I saw in the latest Moonshot presentation. Two cancer programs were specifically mentioned: colorectal cancer and brain tumor. Is it coincidence?
IMO, if it is a sure thing in biotech, then we as retailers can only have leftover.
You don't have a X account? I am so poor that I cannot afford ihub membership.
Recall this news from CNBC. The interesting thing is that the journalist had breast cancer a couple of years ago.
https://www.nbcnews.com/nightly-news/video/new-results-show-vaccine-could-help-fight-brain-cancer-182263877549
https://www.cnbc.com/2023/06/12/experimental-vaccine-shows-promise-in-delaying-the-return-of-aggressive-brain-tumor.html
Hype? How could you know it is hype? It could be a reality about to unfold.
Now look at some of job postings from Sanofi. Is this hype too? BTW, does whosleftholdindabag now pay you more since it seems a risky job now?
Director Digital & Artificial Intelligence
https://en.jobs.sanofi.com/job/cambridge/director-digital-and-artificial-intelligence/20873/63131385440
You are so clueless that you have to go to the other side of the fence to show your stupidity. The only thing you are capable of is hiding behind the scene and clicking the stinky symbol. I am not surprised since your posts reek too.
Ex,
Does it make sense to you now that I have included Sanofi in my BP job postings?
It is not my first stock.
Dude, you make me laugh. If we were so amateurish and you were so confident, you would put all of us on ignore. You are so double think. You are worried to death and you don't miss each post from NWBO longs because your league only pukes nonsense and nothing seminal and genuine. You think you are smarter than whosleftholdindabag? Ask him if he is so desperate that he has to disguise himself and make up stories.
At this stage, you still wish us to see the end of tunnel in 2025? But I already have my champagne ready and play to celebrate in a month. You don't think the news will strike you naysayers like lightening in a month, do you? Well, think whatever you want. Check back with the longs in a month.
Horse,
I am not sure about being better protected. There is no insurance on this regard.
Would you agree that the seven MMs control over at 95% of NWBO share trading? Hypothetically assume the sp price jumps to $10 and you want to sell a certain percentage, MMs don't facilitate your transaction. Why can you do? Lawsuit can be painfully long. Of course, MMs are a lot smarter in terms of setting up retailers.
Gary,
On another note, give a second thought about registering at least some of your shares under your own name. Did you find it is ridiculous that the former SEC employee in charge of spoofing investigation joined MMs legal team to fight NWBO in court?
It is no hurt being proactive.
Gary,
My conjecture it should be a stream of good news. I should say a stream of exciting news. Not every one in investor field knows about NWBO. But I am so certain that all the BPs which have business in oncology know NWBO and they know NWBO a lot better than us. The partnership is certain. It is just the width and depth of the partnership that we need to see. Is the partnership from both the public sectors and private sectors such as all the BPs in oncology business? We will find out after the approval. As an illustration of my point on the possibility that all the BPs in oncology business might like to have partnership with NWBO, take Takeda as an example.
Here is the leadership on oncology from Takeda.
https://www.takedaoncology.com/about/leadership/
Here is the resume of President, Global Oncology Business Unit. Teresa Bitetti used to work at BMS for 18 years before she joined Takeda. I suspect it is commonsense that she would suggest Takeda to reach LP, sign NDA and take a look the first hand data on DCVax-L.
Or should we say: surprises any time? I have to use plural form.
Gary,
Have you seen enough what the dark forces have been doing? Is today's system the same one 30 or 50 years ago? Outside it may look the same. But inside it has more corruption. The worst is the academia corruption which seems like spreading like disease.
BTW, you don't need to put everything under direct registration. What's the big harm to put some of it? At least, you can hedge some of your investment for safety purpose.
Do you know who Elliott Leary is? If you don't, ask your boss.
Are you one of minions hired by whosleftholdindabag? You are. You always play duet with that dude. You can also give heads up to that jondoeuk who I believe is one of his minions too. Laura will do forensic data analysis.
$NWBO Chat GPT:
— Andrew Caravello, DO (@andrewcaravello) April 19, 2024
A CUSIP number is a unique nine-character alphanumeric code that identifies a specific security, such as a stock or a bond, in the United States and Canada. This number is essential for the accurate and efficient clearance and settlement of securities and is used…
Dude might be pissed off because I silenced his buddy whosleftholdindabag.
When I said the longs should forward all the suspicious bashers to Laura Posner, this dude was trying to dissuade my effort.
When BB suggested holding paper certificates, again this dude put a bunch of BS to discourage the longs from doing do. I did the DRS with Fidelity, I know exactly how easy the process is. Being on this board long enough, I can tell how the wolf in sheep skin looks like.
You can brag to someone else whatever your record is. I am so insensitive to your stuff. Yes, I post often. Do I post nonsense? You are trying to put everything about DCVax-L into the frame of your mediocre mindset. I haven't seen anything genuine and seminal from your posts.
Let's see if lately BPs are trying to hire people with expertise on transcriptomic study.
Merck
Senior Scientist, Data-Rich Experimentation
https://www.pharmadiversityjobboard.com/job/senior-scientist-data-rich-experimentation-12541008
Roche
Scientist 3, Translational Oncology
https://roche.wd3.myworkdayjobs.com/en-US/ROG-A2O-GENE/job/Scientist-3--Translational-Oncology_202403-106853-1
Bristol-Myers Squibb
Scientist, Oncogenesis Translational IPS
https://www.talentify.io/job/scientist-oncogenesis-translational-ips-princeton-new-jersey-bristol-myers-squibb-r1578906
AstraZeneca
Postdoctoral Fellow - Profiling the tumor microenvironment using interpretable AI through single cell spatial transcriptomics data
https://www.linkedin.com/jobs/view/postdoctoral-fellow-profiling-the-tumor-microenvironment-using-interpretable-ai-through-single-cell-spatial-transcriptomics-data-at-astrazeneca-3853074207/
GSK
Associate Director, Oncology Genomics
https://jobs.gsk.com/en-gb/jobs/393821
Gilead
Sr Research Scientist I Oncology Bioinformatics, Research Data Science
https://www.biospace.com/job/2886552/sr-research-scientist-i-oncology-bioinformatics-research-data-science
Regeneron
Assoc Computational Scientist - Molecular Profiling and Data Science
https://www.pharmaopportunities.com/assoc-computational-scientist-molecular-profiling-and-data-science-job-12120428/#google_vignette
Sanofi
Global Research Postdoctoral Fellow - AI for Patient Stratification and Precision Medicine
https://sanofi.wd3.myworkdayjobs.com/en-US/SanofiCareers/details/Global-Research-Postdoctoral-Fellow---AI-for-Patient-Stratification-and-Precision-Medicine_R2714796?q=transcriptomic
Abbvie
Senior Scientist II, Bioinformatics - Omics Emerging Technology
https://www.biospace.com/job/2896241/senior-scientist-ii-bioinformatics-omics-emerging-technology
Eli Lilly
https://www.linkedin.com/jobs/view/director-senior-director-computational-biology-at-eli-lilly-and-company-3784109633/
Director/Senior Director - Computational Biology
Dr. Liau mentioned a lot about transcriptomic study in her publications. How is transcriptomic study related to cancer study? ChatGPT gave the reply.
https://scholar.google.com/scholar?hl=en&as_sdt=0%2C44&q=Linda+Liau+%2B+Transcriptomic&btnG=
Cellular and transcriptional immune responses induced by neoadjuvant PD-1 blockade in glioblastoma patients
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE154795
Transcriptomic characterization of GBM tumor and vascular cells and IBSP on patient-delived gliomasphere culture
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE186932
George,
Pardon me for the typos.
Out of curiosity, is Nemesis18 aka whosleftholdindabag a nice boss?
The reason I am asking is that Nemesis18 always likes his minions' posts over weekend. Nemesis18 must force his minions to work a lot over weekend.
George,
Safety is always over convince. Don't think the dark forces have no soul and they corrupt the system. Should Harvard do some background check on Ken Griffin before taking his money? Obviously not.
NWBO longs are complaining about low share price. I think if 10% or 25% of retailers start holding certificate the sp could take off right away.
Now I start thinking that you may be a wolf in sheep skin.
NWBO longs should take this post seriously. If you believe the system is working, the system may fail you in the end. Seriously, if the system were working, DCVax-L should have been available long time ago and tens of thousands of lives, especially many children's lives could have been saved. What kind of huge stakes could possibly make Harvard professor abandon ethic rules and write a hitting piece published on the Thanksgiving day?
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174269450
Does everyone know the meaning of Fails-to-deliver?
https://www.sec.gov/comments/s7-07-23/s70723-20162302-331156.pdf
senti,
The biggest concern should be safety. You aren't saying no broker will take paper certificates, are you? If Schwab will not take them, we can always find another one.
BB,
Thank you for the reminder.
Sorry, my English is probably on elementary school level. If you say something deep, put it as simple as possible.
senti,
What are you talking about? You don't think we know this. Level with me: Do we have security for our shares at least if we do what BB suggested?
Cannot you sense how low these dark forces? Their lawyers even had the audacity using vacation as excuse. These dark forces pushed NWBO to the OTC in the thought that the company would become extinct sooner or later and all their dirty records would disappear without trace. You don't think there are enormous number of fake shares?
Let me ask you a quick question: Did you try it with Fidelity?
You forgot your stamp word "mate". Can you find anyone else uses that word as frequently as you on this board?
When I have time, I'll go through all your posts to see if I can find anything that might intrigue Laura Posner even more.
You need to find a new lawyer.
So you received DCVax-L treatment in 2015. You are still alive. For GBM patients, long-term mortality is nearly 100%. That's why there are only two or three meta-analysis on GBM patients simply because very few GBM patients can live over five or ten years. Have you been on follow-up check?
It should be easy for Laura Posner to go through NWBO data-base to find out who are the patients receiving the treatment in 2015. If you are poor minion, I have no interest. But you could be a billionaire, I suspect all NWBO retailers would appreciate my work if I help Laura Posner to hit the jackpot. You should have taken seriously the post by Red_Right_Hand right after you registered the new alias.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173970623
How about we let her decide on her own? If you are a paralegal working for her, then I agree with you.
Found the contact of Cohen Milstein. NWBO longs, send to Laura Posner anything you feel suspicious. IMO, there could be very rich basher roaming on this board. Cohen Milstein works on contingency basis and we don't need to pay a penny.
https://www.cohenmilstein.com/wp-content/uploads/2022/12/2nd-Amended-Complaint-NWBO-03182024.pdf
Laura H. Posner
Michael B. Eisenkraft
COHEN MILSTEIN SELLERS & TOLL PLLC
88 Pine Street, 14th Floor
New York, New York 10005
Tel: (212) 838-7797
Fax: (212) 838-7745
lposner@cohenmilstein.com
meisenkraft@cohenmilstein.com
Raymond M. Sarola (RS1010)
Cohen Milstein Sellers & Toll PLLC
100-120 N. 18th Street, Suite 1820
Philadelphia, PA 19103
Tel: (267) 479-5700
Fax: (267) 479-5701
rsarola@cohenmilstein.com